IFLR1000

Lonza Group SFr865 accelerated bookbuilding

8/2/2017
Acquisition finance, Share offer
Select tab

SFr 685 million

$ 728.748 million

Completed

8/2/2017

Overview:

  • The Swiss-based Lonza Group placed five million shares through an accelerated bookbuilding process.
  • As a result of the placement, the company was able to raise SFr865 million that was used to partly finance the acquisition of Capsugel.
  • Merrill Lynch International and UBS acted as joint bookrunners for the deal.
  • Lonza is a multinational chemicals and biotechnology company, headquartered in Basel, that has more than eight R&D centres located around the globe.

Jon Moore - Journalist

 

Jurisdictions:

United States
Switzerland
United Kingdom

Deal types:

Acquisition finance
Share offer

Practice area:

Capital markets : Debt

Governing laws:

England and Wales
Switzerland

Industry sectors:

Healthcare
Industrials and manufacturing
Pharmaceuticals and life sciences

Firms:
Bär & Karrer

Party: Lonza Group (Issuer)

Lawyer: Rolf Watter

Homburger

Party: Merrill Lynch International (Bookrunner)

Party: UBS (Bookrunner)

Lawyers: Benedikt Maurenbrecher, Daniel Daeniker, Jürg Frick

Jenner & Block

Party: Lonza Group (Issuer)

Lawyer: Martin Glass

Linklaters

Party: Merrill Lynch International (Bookrunner)

Party: UBS (Bookrunner)

Lawyer: Marco Carbonare

Related deals